Emory University, Georgia Institute of Technology, and University of Georgia under the Regenerative Engineering and Medicine Center (REM) announce the 2020-21 “Therapeutic Delivery Innovation Initiative” collaborative grant program.
This funding mechanism is intended to stimulate new, collaborative research in therapeutic delivery among Georgia Tech, Emory University, and UGA investigators. The collaborative grant team must have a minimum of two investigators and must have an equal partnership of faculty from two of the participating institutions with budgets split between the universities as equally as possible.
This funding mechanism may support collaborative projects at earlier stages of development in the “high risk, high yield” category or projects with exceptionally innovative or novel technology and/or a high potential for clinical or industry translation. Research must be related to drug delivery and may focus on but is not limited to SARS-CoV2 and/or COVID-19 applications. Budgets for these proposals may not exceed $100,000.
Deadline: June 12, 2020